The Demands of the Perfect Dose

Abstract

"According to FDA, the pathway allows drug developers a faster route to improve existing drugs, including new dosage forms that are faster acting or that combine two active ingredients in a new way," he comments. According to Weber, patient-centric principles are being applied in a variety of ways in pharmaceutical development. "Genetic profiling and advanced analytical techniques for example are assisting the personalized/precision medicine approach by providing deep insight into different patient populations and the pharmacokinetic and pharmacodynamic effects of drugs," he says. [...]patients can be more selective in their choice of pharmaceutical products, taking into consideration their efficacy in certain subsets of the populations." "High potency facilities are capital intensive and containment requirements are stringent," he says. [...]it will be more economical and practical for pharmaceutical companies to work alongside outsourcing partners to develop and manufacture their products in a more efficient manner."